Revocation

Decisions of the Unified Patent Court recorded under "Revocation" in UPC Litigation Watch, the case law database maintained by Dhenne Avocats.

Find a decision in three steps

  1. 1. SearchEnter a party name, case number or keyword.
  2. 2. RefineUse the filters to refine your search, then select Filter.
  3. 3. ReadOpen a title. The “Decision with commentary” badge identifies a case note by the firm.
Scope, method and reading key

UPC decisions and orders since 1 June 2023. “Decision with commentary” means the entry contains an analysis by Dhenne Avocats. “Summary available” identifies a summary; “Reference” identifies a record without a detailed case note. Open the entry for the source and, where available, the facts, reasoning and practical implications. The official decision is authoritative.

172 decisions recorded

Pari Pharma v Koninklijke Philips (CFI, 27 November 2025)

27 November 2025 CFI / Milan (IT) Central Division- Section / Revocation Action Decision with commentary

By decision of 27 November 2025, the Milan Central Division, hearing Pari Pharma’s revocation action against Koninklijke Philips’ EP 3 397 329 B1 (air-flow in a nebulizer head), holds claim 1 as granted to lack novelty but maintains the patent as amended…

Read the analysis

UPM-Kymmene v International N&H Denmark (CFI, 21 November 2025)

21 November 2025 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

In an order of 21 November 2025 made after the interim conference, Judge-rapporteur Kupecz of the Munich Central Division set the framework for the hearing in revocation action UPC_CFI_829/2024 brought by UPM-Kymmene Oyj against International N&H Denmark ApS, substituted for Virdia Inc.,…

Read the analysis

IMI Hydronic Engineering Deutschland v Belparts Group (CFI, 3 November 2025)

3 November 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By an order of 31 October 2025, given in revocation action UPC_CFI_104/2025 and counterclaim for infringement UPC_CFI_364/2025, the Paris Central Division declined, despite the agreement of all parties, to apply Rule 340.1 to join that counterclaim with the infringement action pending before…

Read the analysis

bioMérieux UK v Labrador Diagnostics (CFI, 23 October 2025)

23 October 2025 CFI / Milan (IT) Central Division- Section / Revocation Action Decision with commentary

By decision of 23 October 2025 (UPC_CFI_497/2024, revocation action, and UPC_CFI_571/2024, revocation counterclaim), the Milan Central Division ruled on the validity of Labrador Diagnostics' EP 3 756 767, concerning modular point-of-care devices, challenged by bioMérieux UK and several bioMérieux group companies.

Read the analysis

Meril Life Sciences v Edwards Lifesciences (CFI, 20 October 2025)

20 October 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

The Paris Central Division dismisses Meril’s revocation action against Edwards Lifesciences’ EP 4 151 181 (prosthetic heart valve and delivery assembly), maintains the patent as amended by Auxiliary Request 2 and grants the counterclaim for infringement against the Octacor and Octapro systems.

Read the analysis

Brita v AQUASHIELD EUROPE (CFI, 16 October 2025)

16 October 2025 CFI / Munich (DE) Local Division / Counterclaim for revocation Decision with commentary

In an order of 16 October 2025, the Munich Local Division allowed the defendants to withdraw their counterclaim for revocation of Brita's patent EP 2 387 547 (UPC_CFI_564/2024, linked to infringement action UPC_CFI_248/2024), although the division had already ruled on the merits…

Read the analysis

bellissa HAAS v Windhager (CFI, 12 September 2025)

12 September 2025 CFI / Mannheim (DE) Local Division / Counterclaim for revocation Decision with commentary

By a decision of 12 September 2025 (UPC_CFI_338/2024 and UPC_CFI_778/2024), the Mannheim Local Division upheld bellissa HAAS's infringement action against Windhager GmbH based on EP 2 223 589 (bed edging made of interlocking sheet-metal strips) and dismissed the revocation counterclaim.

Read the analysis

*** v Essetre (CFI, 28 July 2025)

28 July 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 28 July 2025 (UPC_CFI_239/2024), the Paris Central Division (Presiding Judge Catallozzi as judge-rapporteur, Judge Zhilova and technically qualified Judge Elmeros) dismissed a revocation action brought by an anonymised claimant against Essetre Holding's EP 2 875 923 B1, which concerns…

Read the analysis

EOFLOW v Insulet (CFI, 22 July 2025)

22 July 2025 CFI / Milan (IT) Central Division- Section / Revocation Action Decision with commentary

In a decision of 22 July 2025 (UPC_CFI_597/2024), given both on EOFLOW’s revocation action and on Insulet’s counterclaim for infringement, the Milan Central Division dismissed by default the revocation action against unitary patent EP 4 201 327, EOFLOW having refused to provide…

Read the analysis

Sibio Technology v Abbott Diabetes Care (CFI, 21 July 2025)

21 July 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 21 July 2025, the Paris Central Division dismisses the revocation action brought by Sibio Technology against Abbott Diabetes Care’s European patent EP 3 831 283 B1, which concerns an on-body glucose monitoring device, and maintains the patent as granted.

Read the analysis

BAUSSMANN Collated Fasteners v Raimund Beck Nageltechnik (CFI, 14 July 2025)

14 July 2025 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 14 July 2025 following the interim conference of 11 July (UPC_CFI_836/2024), the judge rapporteur Kupecz (Munich Central Division) prepared the oral hearing in the revocation action against EP 4 019 790 brought by BAUSSMANN Collated Fasteners against Raimund Beck…

Read the analysis

Texas Instruments EMEA Sales v TOTAL SEMICONDUCTOR (CFI, 9 July 2025)

9 July 2025 CFI / Mannheim (DE) Local Division / Counterclaim for revocation Decision with commentary

By procedural order of 9 July 2025 (UPC_CFI_132/2024), the judge rapporteur Böttcher (Mannheim Local Division) closed the interim procedure in Total Semiconductor's infringement action under EP 2 746 957 against three Texas Instruments companies and in the revocation counterclaim.

Read the analysis

AYLO PREMIUM v DISH Technologies (CFI, 28 May 2025)

28 May 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 28 May 2025, the Paris Central Division, seised by AYLO PREMIUM of a revocation action directed only at the German part of DISH Technologies’ EP 3 822 805 B1 (adaptive rate streaming of content), revokes that German part for…

Read the analysis

Kunststoff KG Nehl v Häfele (CFI, 22 May 2025)

22 May 2025 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 22 May 2025, the judge rapporteur of the Munich Central Division stayed, with effect from 21 May 2025 and at the joint request of the parties, who are negotiating a settlement, the revocation action brought by Kunststoff KG Nehl…

Read the analysis

EOFLOW v Insulet (CFI, 11 April 2025)

11 April 2025 CFI / Milan (IT) Central Division- Section / Revocation Action Decision with commentary

By order of 11 April 2025 (UPC_CFI_597/2024), the Milan Central Division rules on three issues in EOFLOW’s revocation action against Insulet’s EP 4201327, in which Insulet has counterclaimed for infringement.

Read the analysis

NJOY Netherlands v Juul Labs International (CFI, 28 February 2025)

28 February 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 28 February 2025, the Paris Central Division, ruling on NJOY Netherlands’ revocation action against Juul Labs International’s EP 3 504 989 (“Vaporization device systems”), holds that claim 1 as granted contains added matter, but maintains the patent as amended…

Read the analysis

Zentiva France v Sanofi Mature IP (CFI, 24 January 2025)

24 January 2025 CFI / Munich (DE) Local Division / Counterclaim for revocation Decision with commentary

In a procedural order of 24 January 2025, the Munich Local Division set the timetable for the proceedings on EP 2 493 466 between the Sanofi companies and Accord Healthcare, STADA, Dr Reddy’s and Zentiva (UPC_CFI_145, 146, 147, 148, 374, 463, 496…

Read the analysis

NJOY Netherlands v VMR Products (CFI, 22 January 2025)

22 January 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 22 January 2025 (UPC_CFI_310/2023), the Paris Central Division ruled on NJOY Netherlands’ revocation action against VMR Products’ EP 3 613 453, which concerns an electronic cigarette with charging contacts.

Read the analysis

NJOY Netherlands v VMR Products (CFI, 21 January 2025)

21 January 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 21 January 2025 (UPC_CFI_311/2023), the Paris Central Division dismissed NJOY Netherlands’ revocation action against VMR Products’ EP 3 626 092, which concerns an electronic cigarette whose cartomizer has a translucent portion through which the liquid can be seen,…

Read the analysis

NJOY Netherlands v Juul Labs International (CFI, 17 January 2025)

17 January 2025 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 17 January 2025 (UPC_CFI_316/2023), the Paris Central Division revoked in its entirety Juul Labs International’s EP 3 430 921, which concerns vaporisation devices, for Belgium, France, Germany, Italy, Luxembourg, the Netherlands, Portugal and Sweden, on NJOY Netherlands’ revocation…

Read the analysis

Mammut Sports Group v Ortovox Sportartikel (CFI, 14 January 2025)

14 January 2025 CFI / Düsseldorf (DE) Local Division / Counterclaim for revocation Decision with commentary

In a decision of 14 January 2025 (UPC_CFI_16/2024), given in German, the Düsseldorf Local Division upholds Ortovox Sportartikel's EP 3 466 498 (avalanche transceiver), dismisses the counterclaim for revocation of Mammut Sports Group AG and Mammut Sports Group GmbH and finds that…

Read the analysis

Tandem Diabetes Care Europe v Roche Diabetes Care (CFI, 18 December 2024)

18 December 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 18 December 2024 (UPC_CFI_454/2023), the Paris Central Division dismissed Tandem Diabetes Care’s revocation action against Roche Diabetes Care’s EP 2 196 231, which concerns a system for ambulatory drug infusion, and maintained the patent as granted.

Read the analysis

NJOY Netherlands v VMR Products (CFI, 29 November 2024)

29 November 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 29 November 2024 (UPC_CFI_307/2023), the Paris Central Division dismissed NJOY Netherlands' revocation action against VMR Products' EP 2 875 740 (a vaporizer whose cartomizer is held by two magnets of opposite polarity), which was maintained as granted for…

Read the analysis

NJOY Netherlands v VMR Products (CFI, 27 November 2024)

27 November 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 27 November 2024 (UPC_CFI_308/2023), the Paris Central Division revoked in its entirety VMR Products’ European patent EP 3 456 214, which concerns a vaporiser (electronic cigarette) with a window through which part of the cartomizer receiving chamber can…

Read the analysis

NJOY Netherlands v Juul Labs (CFI, ORD_598483/2023, 5 November 2024)

5 November 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision of 5 November 2024 (UPC_CFI_315/2023), the Paris Central Division dismissed NJOY Netherlands’ revocation action against Juul Labs International’s EP 3 504 991, which concerns a cartridge for a vaporisation device, and upheld the patent as granted.

Read the analysis

NJOY Netherlands v Juul Labs (CFI, ORD_598482/2023, 5 November 2024)

5 November 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 5 November 2024 (UPC_CFI_309/2023, ACT_571669/2023), the Paris Central Division revoked Juul Labs International's EP 3 498 115, which concerns a cartridge for a vaporisation device, for all the states concerned, at the request of NJOY Netherlands.

Read the analysis

NanoString Technologies Europe v President and Fellows of Harvard College (CFI, 17 October 2024)

17 October 2024 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

In a decision of 17 October 2024 (UPC_CFI_252/2023), the Munich Central Division upheld NanoString Technologies Europe’s revocation action against EP 2 794 928 of the President and Fellows of Harvard College, which concerns a method of detecting multiple analytes through successive hybridisations…

Read the analysis

BITZER Electronics v Carrier (CFI, 29 July 2024)

29 July 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By decision of 29 July 2024 (UPC_CFI_263/2023, ACT_555899/2023), the Paris Central Division dismissed BITZER Electronics' revocation action against claim 1 of Carrier Corporation's EP 3 414 708, which concerns cold chain monitoring of perishable goods, and maintained the patent as amended by…

Read the analysis

Meril Italy v Edwards Lifesciences (CFI, 19 July 2024)

19 July 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

In a decision on the merits of 19 July 2024, the Paris Central Division dismissed Meril Italy Srl’s revocation action (UPC_CFI_255/2023) and the counterclaims for revocation of Meril GmbH and Meril Life Sciences Pvt Ltd, which had been referred by the Munich…

Read the analysis

Meril v Edwards Lifesciences (CFI, 19 July 2024)

19 July 2024 CFI / Paris (FR) Central Division - Seat / Counterclaim for revocation Decision with commentary

In a decision of 19 July 2024, the Paris Central Division ruled jointly on Meril Italy's revocation action (UPC_CFI_255/2023) and on the counterclaims for revocation of Meril GmbH and Meril Life Sciences referred by the Munich Local Division (UPC_CFI_15/2023), directed against Edwards…

Read the analysis

Sanofi-Aventis Deutschland v Amgen (CFI, 16 July 2024)

16 July 2024 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

In a decision on the merits of 16 July 2024, the Munich Central Division ruled on the revocation action brought by Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Groupe and Sanofi Winthrop Industrie S.A.

Read the analysis

Regeneron Pharmaceuticals v Amgen (CFI, 16 July 2024)

16 July 2024 CFI / Munich (DE) Central Division - Section / Counterclaim for revocation Decision with commentary

In a decision on the merits of 16 July 2024, the Munich Central Division ruled on Regeneron Pharmaceuticals’ counterclaim for revocation against Amgen’s EP 3 666 797, which protects, in medical use format, a monoclonal antibody binding to the catalytic domain of…

Read the analysis

Stäubli TecSystems v Defendants (anonymised) (CFI, 16 May 2024)

16 May 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By order of 16 May 2024 (UPC_CFI_372/2023, ACT_580824/2023), the Paris Central Division held that Stäubli TecSystems' revocation action against EP 3 170 639 had become devoid of purpose, the (anonymised) proprietors having acknowledged the claim and surrendered the patent with retroactive effect…

Read the analysis

BITZER Electronics v Carrier (CFI, 5 April 2024)

5 April 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By an order of 5 April 2024 (UPC_CFI_263/2023, ACT_555899/2023), judge-rapporteur Catallozzi of the Paris Central Division recorded the decisions taken at the interim conference of 2 April 2024 in the revocation action brought by BITZER Electronics A/S against Carrier Corporation over EP…

Read the analysis

Sanofi v Amgen (CFI, 24 February 2024)

24 February 2024 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 27 February 2024 (ORD_10396/2024 and ORD_10398/2024), the judge-rapporteur of the Munich Central Division decided, with the agreement of all parties, to deal jointly with Sanofi's revocation action against Amgen's EP 3 666 797 (UPC_CFI_1/2023, ACT_459505/2023) and Regeneron's counterclaim for…

Read the analysis

Sanofi-Aventis Deutschland v Amgen (CFI, 24 January 2024)

24 January 2024 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 24 January 2024 (UPC_CFI_1/2023, ORD_2233/2024), the judge-rapporteur of the Munich Central Division admitted into Sanofi's revocation action against Amgen's EP 3 666 797 a six-page letter and expert declarations responding to points first raised in the rejoinder, and refused…

Read the analysis

NJOY Netherlands v VMR Products (CFI, 22 January 2024)

22 January 2024 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By order of 22 January 2024 (UPC_CFI_308/2023, App_159/2024), the judge-rapporteur of the Paris Central Division declared that VMR Products' defence to revocation was served on NJOY on 13 December 2023, the date on which the Registry sent the corrected version.

Read the analysis

NanoString Technologies Europe v President and Fellows of Harvard College (CFI, 30 October 2023)

30 October 2023 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 30 October 2023 (UPC_CFI_252/2023, ORD_574057/2023), the judge-rapporteur of the Munich Central Division ordered NanoString Technologies Europe, claimant in the revocation action against President and Fellows of Harvard College's EP 2 794 928, to provide security for costs of EUR…

Read the analysis

Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023)

11 October 2023 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By procedural order of 11 October 2023 (UPC_CFI_75/2023, ACT_464985/2023), the judge-rapporteur of the Munich section of the Central Division, in Astellas Institute for Regenerative Medicine's revocation action against EP 3 056 563 held by Healios, Riken and Osaka University, ruled that the…

Read the analysis

Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_80/2023, 11 October 2023)

11 October 2023 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By procedural order of 11 October 2023 (UPC_CFI_80/2023, ORD_579545/2023, ACT_465342/2023), the judge-rapporteur of Panel 1 of the Munich Central Division (A. Kupecz), in Astellas Institute for Regenerative Medicine's revocation action against EP 3 056 564 held by Healios K.K and Osaka University,…

Read the analysis

NanoString Technologies Europe v President and Fellows of Harvard College (CFI, 4 October 2023)

4 October 2023 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By order of 4 October 2023 (UPC_CFI_252/2023, ACT_551180/2023), the judge-rapporteur of the Munich Central Division informed the parties that the preliminary objection lodged by President and Fellows of Harvard College, defendant to NanoString Technologies Europe's revocation action against EP 2 794 928…

Read the analysis

BITZER Electronics v Carrier (CFI, 5 July 2023)

5 July 2023 CFI / Paris (FR) Central Division - Seat / Revocation Action Decision with commentary

By procedural order of 5 July 2023 (PR_ACT_536477/2023), the standing judge of the Paris Central Division, to whom the Registry had referred the matter under Rule 16.5 RoP in BITZER Electronics' revocation action against Carrier's EP 3 414 708, sent the proceedings…

Read the analysis

Sanofi-Aventis Deutschland v Amgen (CFI, 29 June 2023)

29 June 2023 CFI / Munich (DE) Central Division - Section / Revocation Action Decision with commentary

By procedural order of 29 June 2023, the Munich section of the Central Division admitted as exhibits to the statement for revocation the documents filed by Sanofi-Aventis Deutschland, Sanofi-Aventis Groupe and Sanofi Winthrop Industrie by way of a generic procedural application (No.

Read the analysis